Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
18m agoLinde Declares Dividend in Second Quarter 2026
43m agoAmesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
44m agoCreator Platform Beats Global Field Two Years Running, as Social Content Evolves into Social Commerce
44m agoAmerican Rebel Holdings (NASDAQ: AREB) Announces Nasdaq Trading Resumption and Provides Shareholder Update
45m agoPersonalization at Scale: 3,000 Custom Baseballs, One Unforgettable Adobe Summit
Catalyst Pharmaceuticals Inc logo

Catalyst Pharmaceuticals Inc

About

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 6 2026
Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference
Feb 25 2026
Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance
Feb 24 2026
Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference
Feb 11 2026
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
Jan 8 2026
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies

Financials

Revenue
$588.99 M
Market Cap
$3.03 B
P/E Ratio
14.70
EPS
1.68

Community Chat

Ask AI

6ix6ix